Skip to main content

Monsanto's Bid To Block Evidence From Roundup Trials Denied

Monsanto's Bid To Block Evidence From Roundup Trials Denied

Monsanto's Bid To Block Evidence From Roundup Trials Denied

Introduction

On Monday, January 28, U.S. District Judge Vince Chhabria of the Northern District of California denied Monsanto's bid to exclude vital evidence from an upcoming bellwether trial linked to Roundup's carcinogenic nature.

Judge Chhabria suggested that plaintiffs can introduce the evidence during the first phase of the trial. There were reports that pointed at Monsanto's alleged attempt to ghostwrite studies and influence researchers investigating glyphosate exposure side-effects. Plaintiffs' attorneys asserted that the evidence associated with Monsanto's alleged misconduct is crucial in proving claims filed against the agro-giant. However, Bayer maintained that the information in the internal company documents was merely an attempt to distract jurors from actual scientific evidence. Judge Chhabria admitted that though his decision was disappointing for Monsanto, any proof that confirms the company's involvement in hiding the risks of glyphosate exposure is completely relevant to the bellwether trials. The federal judge's order is applicable to the first trial set to begin on February 25, involving claims filed by a California resident as well as two future trials. Bayer has filed another motion to bar evidence being presented for claims filed by a California couple in San Francisco Superior Court and requested to bifurcate the trial scheduled for March, into two phases.

There are more than 600 Roundup lawsuits pending in the multidistrict litigation, which are centralized in the Northern District of California for coordinated pretrial proceedings. All those lawsuits raise allegations that Roundup use causes non-Hodgkin’s lymphoma, a deadly form of cancer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.